Free Trial

Pharmaceutical plant idled despite effort to save jobs

CHARLESTON, W.Va. (AP) — A West Virginia pharmaceutical plant that employed nearly 1,500 people has been idled despite a last-ditch attempt by labor and advocacy groups to keep it open.

Time ran out Saturday for workers at the former Mylan pharmaceuticals plant in Morgantown, the Charleston Gazette-Mail reported.

Drugmaker Viatris Inc. announced in December that it would lay off workers at the end of July. The plant was formerly operated by the generic drug company Mylan, which merged with Upjohn last year to form the new company. Viatris, which announced it would slash 20% of its workforce worldwide, is now one of the world’s dominant manufacturers in the generics industry.

The moves left workers scrambling to find new jobs as the major employer left West Virginia, a state that is often trying to lure new companies to uplift its stagnant economy.

Dozens of labor and advocacy groups called on President Joe Biden on July 21 to intervene in the company's plan. A new campaign led by Our Revolution, a political nonprofit organization founded by Bernie Sanders, had urged Biden to use the Defense Production Act to stop the closure and convene a task force to determine how the plant might continue producing pharmaceutical or medical goods.

The White House has not responded publicly to the closure or the group’s letter, the Gazette-Mail reported.

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: